Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA replication licensing in peripheral B-cell lymphoma.

Ellen C Obermann1, Kathryn Leigh Eward, Ahmet Dogan

  • 1Department of Histopathology, University College London, Rockefeller Building, University Street, London, WC1E 6JJ, United Kingdom.

The Journal of Pathology
|February 1, 2005
PubMed
Summary

Peripheral B-cell lymphomas like SLL/CLL and MCL are in G1 phase, not quiescent. High-growth lymphomas show cell cycle differences, aiding diagnosis and prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes, patterns of relapse and molecular landscape of advanced stage High Grade B-cell Lymphoma.

Blood advances·2026
Same author

Antimicrobial resistance profiles of ESKAPE pathogens isolated in a microbiology laboratory in Somalia: a two-year retrospective study.

BMC infectious diseases·2026
Same author

Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma.

Blood·2026
Same author

Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

Blood advances·2026
Same author

Deployment of AI-driven automated quality control of whole-slide images in a large tertiary cancer center.

Journal of pathology informatics·2026
Same author

Genomic features do not account for differences in multiple myeloma risk by ancestry.

Blood cancer discovery·2026

Area of Science:

  • Hematology
  • Cell Biology
  • Oncology

Background:

  • Peripheral B-cell lymphomas (PBCLs) are lymphoid neoplasms.
  • PBCLs are categorized into low- and high-growth fraction subtypes.
  • Understanding cell cycle regulation is crucial for lymphomagenesis research.

Purpose of the Study:

  • To investigate the regulation of DNA replication licensing during B-cell lymphomagenesis.
  • To determine the precise cell cycle state of various B-cell lymphomas.
  • To explore the potential of cell cycle markers for diagnosis and prognosis.

Main Methods:

  • Combined analysis of origin licensing factors Mcm2 and geminin.
  • Utilized proliferation marker Ki67.
  • Examined SLL/CLL, MCL, DLBCL, and Burkitt lymphoma samples.

Related Experiment Videos

Main Results:

  • Neoplastic lymphocytes in SLL/CLL and MCL reside in an "in-cycle" G1 state, not quiescent G0.
  • Absence of geminin in SLL/CLL and MCL suggests failed cell cycle progression.
  • DLBCL and Burkitt lymphoma show differential geminin expression, with a higher geminin/Ki67 ratio in more aggressive types.

Conclusions:

  • Cell cycle control is abrogated during B-cell lymphomagenesis.
  • Combined analysis of Mcm2 and geminin provides insights into lymphoma cell cycle states.
  • These factors may aid in treatment decisions and prognosis for hematopoietic malignancies.